Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00171158
What this trial is testing

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Who this might be right for
Philadelphia Chromosome Positive CML
Novartis Pharmaceuticals 260
Testing effectiveness (Phase 2)UnknownNCT02268370
What this trial is testing

Treatment-free Remission Accomplished With Dasatinib in Patients With CML

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 131
Testing effectiveness (Phase 2)Study completedNCT01593254
What this trial is testing

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 262
Early research (Phase 1)Study completedNCT00047502
What this trial is testing

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT00450450
What this trial is testing

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+7 more
Children's Oncology Group 27
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Early research (Phase 1)Ended earlyNCT00618696
What this trial is testing

Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00067028
What this trial is testing

Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myeloid Leukemia
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)UnknownNCT03883100
What this trial is testing

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation

Who this might be right for
Chronic Myeloid Leukemia - Accelerated Phase
Ascentage Pharma Group Inc. 23
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Large-scale testing (Phase 3)Looking for participantsNCT03459534
What this trial is testing

The Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more
Il-Yang Pharm. Co., Ltd. 173
Large-scale testing (Phase 3)Study completedNCT02829775
What this trial is testing

Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Who this might be right for
Chronic Myelogenous LeukemiaMalignant MelanomaRenal Cell Carcinoma
Hoffmann-La Roche 9
Testing effectiveness (Phase 2)Study completedNCT00378534
What this trial is testing

Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Not applicableStudy completedNCT05893836
What this trial is testing

Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia

Who this might be right for
Chronic Myeloid Leukaemia
Novartis Pharmaceuticals 555
Testing effectiveness (Phase 2)UnknownNCT03241199
What this trial is testing

The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia Chromosome Positive CML
The University of Hong Kong 15
Not applicableLooking for participantsNCT07091019
What this trial is testing

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Novartis Pharmaceuticals 1,000
Testing effectiveness (Phase 2)Study completedNCT00034684
What this trial is testing

Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

Who this might be right for
LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+2 more
Merck Sharp & Dohme LLC 132
Next Page